KR100720973B1 - 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물 - Google Patents

천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물 Download PDF

Info

Publication number
KR100720973B1
KR100720973B1 KR1020050022772A KR20050022772A KR100720973B1 KR 100720973 B1 KR100720973 B1 KR 100720973B1 KR 1020050022772 A KR1020050022772 A KR 1020050022772A KR 20050022772 A KR20050022772 A KR 20050022772A KR 100720973 B1 KR100720973 B1 KR 100720973B1
Authority
KR
South Korea
Prior art keywords
composition
histamine
orientin
isorientin
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020050022772A
Other languages
English (en)
Korean (ko)
Other versions
KR20070039406A (ko
Inventor
우성식
김동선
도선길
이영철
김미란
허영문
오미선
조태형
Original Assignee
주식회사 유니젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020050022772A priority Critical patent/KR100720973B1/ko
Application filed by 주식회사 유니젠 filed Critical 주식회사 유니젠
Priority to JP2008501819A priority patent/JP2008533131A/ja
Priority to CNA2006800086720A priority patent/CN101203228A/zh
Priority to US11/908,927 priority patent/US20080214658A1/en
Priority to CA002601046A priority patent/CA2601046A1/en
Priority to EP06716434A priority patent/EP1863498A2/en
Priority to AU2006223734A priority patent/AU2006223734B2/en
Priority to PCT/KR2006/000984 priority patent/WO2006098603A2/en
Priority to BRPI0608546-6A priority patent/BRPI0608546A2/pt
Publication of KR20070039406A publication Critical patent/KR20070039406A/ko
Application granted granted Critical
Publication of KR100720973B1 publication Critical patent/KR100720973B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A61H39/04Devices for pressing such points, e.g. Shiatsu or Acupressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/01Constructive details
    • A61H2201/0157Constructive details portable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/01Constructive details
    • A61H2201/0192Specific means for adjusting dimensions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16Physical interface with patient
    • A61H2201/1683Surface of interface
    • A61H2201/169Physical characteristics of the surface, e.g. material, relief, texture or indicia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00Devices for specific parts of the body
    • A61H2205/06Arms
    • A61H2205/065Hands
    • A61H2205/067Fingers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020050022772A 2005-03-18 2005-03-18 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물 Expired - Fee Related KR100720973B1 (ko)

Priority Applications (9)

Application Number Priority Date Filing Date Title
KR1020050022772A KR100720973B1 (ko) 2005-03-18 2005-03-18 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물
CNA2006800086720A CN101203228A (zh) 2005-03-18 2006-03-17 用于抗组胺的含异荭草素的组合物
US11/908,927 US20080214658A1 (en) 2005-03-18 2006-03-17 Composition Comprising Isoorientin for Suppressing Histamine
CA002601046A CA2601046A1 (en) 2005-03-18 2006-03-17 Composition comprising isoorientin for suppressing histamine
JP2008501819A JP2008533131A (ja) 2005-03-18 2006-03-17 イソオリエンチンを含むヒスタミン抑制用組成物
EP06716434A EP1863498A2 (en) 2005-03-18 2006-03-17 Composition comprising isoorientin for suppressing histamine
AU2006223734A AU2006223734B2 (en) 2005-03-18 2006-03-17 Composition comprising isoorientin for suppressing histamine
PCT/KR2006/000984 WO2006098603A2 (en) 2005-03-18 2006-03-17 Composition comprising isoorientin for suppressing histamine
BRPI0608546-6A BRPI0608546A2 (pt) 2005-03-18 2006-03-17 composição farmacêutica, e, uso de isoorientina derivada naturalmente

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050022772A KR100720973B1 (ko) 2005-03-18 2005-03-18 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물

Publications (2)

Publication Number Publication Date
KR20070039406A KR20070039406A (ko) 2007-04-12
KR100720973B1 true KR100720973B1 (ko) 2007-05-22

Family

ID=36992143

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020050022772A Expired - Fee Related KR100720973B1 (ko) 2005-03-18 2005-03-18 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물

Country Status (9)

Country Link
US (1) US20080214658A1 (enExample)
EP (1) EP1863498A2 (enExample)
JP (1) JP2008533131A (enExample)
KR (1) KR100720973B1 (enExample)
CN (1) CN101203228A (enExample)
AU (1) AU2006223734B2 (enExample)
BR (1) BRPI0608546A2 (enExample)
CA (1) CA2601046A1 (enExample)
WO (1) WO2006098603A2 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101050129B1 (ko) * 2008-06-18 2011-07-19 주식회사 한국인삼공사 알레르기 질환 예방 또는 치료용 조성물
KR20220059060A (ko) * 2020-11-02 2022-05-10 인천대학교 산학협력단 갯끈풀 추출물을 유효성분으로 포함하는 염증 또는 아토피 피부염의 개선, 예방 또는 치료용 조성물
WO2022250313A1 (ko) * 2021-05-27 2022-12-01 주식회사 유니베라 알로에 베라 꽃 추출물, 또는 알로에 베라 꽃 추출물 및 알로에 베라 다당체를 유효성분으로 함유하는 피부 보습, 재생 촉진 및 상처 치료용 조성물
KR20220160177A (ko) * 2021-05-27 2022-12-06 주식회사 유니베라 알로에 꽃 추출물을 유효성분으로 함유하는 피부 보습용 조성물

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
CN100544715C (zh) 2002-04-30 2009-09-30 尤尼根制药公司 作为治疗剂的包含无取代b环类黄酮和黄烷混合物的组合物
JP4684893B2 (ja) * 2003-03-27 2011-05-18 ユニジェン インク. 炎症性及び血液循環疾患の治療及び予防活性を示す、竹抽出物並びにそれから分離された化合物を含有する組成物
WO2004089392A1 (en) 2003-04-04 2004-10-21 Unigen Pharmaceuticals, Inc. Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
KR100720971B1 (ko) * 2004-06-11 2007-05-22 주식회사 유니젠 대나무 또는 대나무 추출물을 포함하는 안드로젠 효능성조성물
JP2007045755A (ja) * 2005-08-10 2007-02-22 Kameda Seika Co Ltd 美白剤、抗アレルギー剤及び食料品
KR100761248B1 (ko) 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물
KR101702056B1 (ko) * 2009-11-16 2017-02-03 주식회사 유니베라 피부세포증식 촉진, 항산화 및 항알러지 효과가 우수한 알로에 베라 새순 농축물 또는 추출물
FR2956324A1 (fr) * 2010-01-18 2011-08-19 Valerie Baille Complexe vegetal comprenant un extrait polyphenolique de bambou
CN101843612B (zh) * 2010-05-21 2012-01-11 暨南大学 异荭草苷作为制备抗呼吸道合胞病毒的药物的用途
CN102285976A (zh) * 2011-09-27 2011-12-21 天津市尖峰天然产物研究开发有限公司 从竹叶黄酮中提取异荭草素的方法
CN102743375A (zh) * 2012-04-28 2012-10-24 苏州凯祥生物科技有限公司 异荭草素的用途及其药物组合物
KR20150019505A (ko) * 2013-08-14 2015-02-25 대화제약 주식회사 플라본-6-c-글루코스 유도체를 유효성분으로 함유하는 신경정신질환의 치료 또는 예방용 약학적 조성물
CN116349706B (zh) * 2021-12-27 2025-06-17 中国科学院植物研究所 水稻叶片提取物在杀虫中的应用
CN116349698B (zh) * 2021-12-27 2025-06-17 中国科学院植物研究所 水稻叶片提取物在抑制植物生长中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1171292A (ja) 1997-08-29 1999-03-16 Masatoshi Nakano 皮膚外用剤

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201776A (en) * 1977-01-31 1980-05-06 The Green Cross Corporation Food additive for reinforcing foods deficient in fiber content
US5106616A (en) * 1988-01-14 1992-04-21 Carrington Laboratories, Inc. Administration of acemannan
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
JPS61233627A (ja) * 1985-04-10 1986-10-17 Agency Of Ind Science & Technol 肥満細胞脱顆粒抑制剤
US5098709A (en) * 1987-07-21 1992-03-24 Kang Kwon J Method of administrating a fused salt from natural substances, namely ginkgo, persimmon, pine, and bamboo in the treatment of inflammations
JPH05271088A (ja) * 1991-12-27 1993-10-19 Ruibosuteii Japan:Kk 皮膚疾患・免疫反応による組織障害改善治療剤
JPH05271090A (ja) * 1991-12-27 1993-10-19 Ruibosuteii Japan:Kk 活性酸素消去・除去剤
JPH06199690A (ja) * 1992-03-06 1994-07-19 Yunie:Kk 脳代謝促進・脳機能改善剤
JP3811198B2 (ja) * 1993-11-17 2006-08-16 株式会社創研 米からの抗アレルギー剤
TW235922B (en) * 1994-07-06 1994-12-11 Amboo Devise Co Ltd A production process of deodorant
JPH0840923A (ja) * 1994-07-28 1996-02-13 Masatoshi Nakano 栄養補助剤
HK1038700A1 (zh) * 1999-07-23 2002-03-28 E-L Management Corp. 含有含羞草属酚类化合物的组合物
AU2001246876A1 (en) * 2000-04-10 2001-10-23 Takara Bio Inc. Remedies
AU2001246877A1 (en) * 2000-04-11 2001-10-23 Takara Bio Inc. Remedies
US20030170186A1 (en) * 2000-04-18 2003-09-11 Bernadette Geers Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition
US20020146467A1 (en) * 2001-02-08 2002-10-10 Jung Kyu Yong Herbal composition for the prevention and treatment of dementia
US20040185124A1 (en) * 2002-10-24 2004-09-23 Hiromichi Hayashi Health food and antitumor agent
US20030125264A1 (en) * 2001-12-29 2003-07-03 Kimberly-Clark Worldwide, Inc. Methods For Treating Wounds
JP2003212786A (ja) * 2002-01-16 2003-07-30 Univ Nihon 竹の抽出成分を有効成分とする皮膚外用薬
JP4684893B2 (ja) * 2003-03-27 2011-05-18 ユニジェン インク. 炎症性及び血液循環疾患の治療及び予防活性を示す、竹抽出物並びにそれから分離された化合物を含有する組成物
CN1528197A (zh) * 2003-10-08 2004-09-15 ƽ 竹叶抗氧化物及其用途
US7678920B2 (en) * 2004-04-08 2010-03-16 Dow Agrosciences Llc Insecticidal N-substituted sulfoximines
KR100720971B1 (ko) * 2004-06-11 2007-05-22 주식회사 유니젠 대나무 또는 대나무 추출물을 포함하는 안드로젠 효능성조성물
KR100761248B1 (ko) * 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1171292A (ja) 1997-08-29 1999-03-16 Masatoshi Nakano 皮膚外用剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
논문

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101050129B1 (ko) * 2008-06-18 2011-07-19 주식회사 한국인삼공사 알레르기 질환 예방 또는 치료용 조성물
KR20220059060A (ko) * 2020-11-02 2022-05-10 인천대학교 산학협력단 갯끈풀 추출물을 유효성분으로 포함하는 염증 또는 아토피 피부염의 개선, 예방 또는 치료용 조성물
KR102488562B1 (ko) * 2020-11-02 2023-01-12 인천대학교 산학협력단 갯끈풀 추출물을 유효성분으로 포함하는 염증 또는 아토피 피부염의 개선, 예방 또는 치료용 조성물
WO2022250313A1 (ko) * 2021-05-27 2022-12-01 주식회사 유니베라 알로에 베라 꽃 추출물, 또는 알로에 베라 꽃 추출물 및 알로에 베라 다당체를 유효성분으로 함유하는 피부 보습, 재생 촉진 및 상처 치료용 조성물
KR20220160177A (ko) * 2021-05-27 2022-12-06 주식회사 유니베라 알로에 꽃 추출물을 유효성분으로 함유하는 피부 보습용 조성물
KR102543123B1 (ko) * 2021-05-27 2023-06-13 주식회사 유니베라 알로에 꽃 추출물을 유효성분으로 함유하는 피부 보습용 조성물

Also Published As

Publication number Publication date
WO2006098603A2 (en) 2006-09-21
AU2006223734B2 (en) 2012-03-29
AU2006223734A1 (en) 2006-09-21
CN101203228A (zh) 2008-06-18
BRPI0608546A2 (pt) 2010-11-16
US20080214658A1 (en) 2008-09-04
EP1863498A2 (en) 2007-12-12
KR20070039406A (ko) 2007-04-12
JP2008533131A (ja) 2008-08-21
CA2601046A1 (en) 2006-09-21
WO2006098603A3 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
KR100720973B1 (ko) 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물
JP7779656B2 (ja) カンナビジオール製剤及びその使用
CN107949394B (zh) 黑豆叶提取物在制备用于预防或治疗代谢综合征的药物中的用途
US20080293644A1 (en) Guava extract
CN1566124A (zh) 山茱萸提取物及其用途
SK282672B6 (sk) Zmesi pripraviteľné zo semien Eugenia Jambolana Lamarck, spôsob ich prípravy a prípravy ich zložiek, liečivo a ich použitie
EP3639817B1 (en) Compositions containing pterosin compound and derivatives thereof active ingredients for prevention or treatment of degenerative brain diseases
JP7303582B2 (ja) インディアングーズベリー抽出物と大麦若葉抽出物との複合物(ib複合物)を有効成分として含む肥満及び/または糖尿を伴うメタボリックシンドロームの予防、改善治療用組成物
JP2005082509A (ja) 血糖値上昇抑制剤およびage生成阻害剤
WO2022215441A1 (ja) 新規ポリフェノール化合物
WO2023286977A1 (ko) 수용화 매스틱 검 또는 감태나무 추출물을 이용한 항알러지용 조성물
JP5549008B2 (ja) イモ焼酎粕又はそれに由来する物質を含む抗アレルギー剤又は抗アトピー性炎症剤
KR20120115963A (ko) 마 추출물을 포함하는 심혈관계 질환의 예방 또는 치료용 조성물
US11452708B2 (en) Discovery of potent [alpha]-glucosidase inhibitors from Heterophragma adenophyllum
EP4349845A1 (en) Novel isoflavone compound
KR102044232B1 (ko) 갈색거저리 성충으로부터 BACE-1 또는 AChE에 대한 저해활성을 갖는 화합물을 분리하는 방법
KR20130046115A (ko) 시링가레시놀을 포함하는 혈관 노화 억제용 조성물
US20070207229A1 (en) Inhibitor of blood glucose level elevation and inhibitor of age generation comprising acerola leaf extract and food product comprising either thereof
JP7254974B2 (ja) キサンチンオキシダーゼ活性阻害用組成物
JP2001206893A (ja) 新規α−アミラーゼ阻害活性物質、その製造方法及びその用途
KR102044234B1 (ko) 갈색거저리 성충으로부터 분리한 화합물을 유효성분으로 포함하는 알츠하이머의 예방 또는 치료용 조성물
KR20250171747A (ko) 김네마 이노도룸 (Gymnema inodorum) 추출물 또는 이로부터 분리한 화합물을 유효성분으로 포함하는 근육질환 예방 또는 치료용 조성물
KR100516189B1 (ko) 허수테논을 포함하는, 갭 결합을 통한 세포간 정보전달의억제 및 항상성의 불균형과 관련된 질환의 예방 또는치료용 조성물
KR101776942B1 (ko) 코우메스탄계 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 대사성 질환 또는 이들의 합병증의 예방 또는 치료용, 또는 항산화용 조성물
KR100516192B1 (ko) 허수테논을 포함하는 건강 증진용 식품

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction

St.27 status event code: A-5-5-P10-P19-oth-PG1701

Patent document republication publication date: 20080424

Republication note text: Request for Correction Notice (Document Request)

Gazette number: 1007209730000

Gazette reference publication date: 20070522

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20130509

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20140514

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20150517

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20150517

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301